It has been almost two decades since the first link between microRNAs and cancer was
established. In the ensuing years, this abundant class of short noncoding regulatory RNAs …

The volume of point of care (POC) testing continues to grow steadily due to the increased
availability of easy-to-use devices, thus making it possible to deliver less costly care closer …

Defects in chromatin modifiers and remodelers have been described both for hematological
and solid malignancies, corroborating and strengthening the role of epigenetic aberrations …

There is growing evidence that regions of the genome that cannot encode proteins play an
important role in diseases. These regions are usually transcribed into long non-coding …

The development of simple, robust, and reliable microRNA (miRNA) detection methods is of
great significance in the studies of the biological function of miRNAs, molecular diagnostics …

Abstract miRNAs have emerged, in the last decade, as key players in the carcinogenic
process, with many candidates identified as playing important roles in many aspects of …

Background Breast cancer patients under neoadjuvant chemotherapy includes a
heterogeneous group of patients who eventually develop distal disease, not detectable by …

MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes
at the post-transcriptional phase. miRNAs are considered to have roles in the development …

microRNA-21 (miR-21) is the most commonly upregulated miRNA in solid tumors. This
cancer-associated microRNA (oncomiR) regulates various downstream effectors associated …

MicroRNAs (miRNA) are short non-coding RNA molecules that regulate gene expression.
miRNAs profiles are specific for cell lineages and tissues, and their changes reflect …